NIMC
NWQ Investment Management Company’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-178,402
| Closed | -$3.05M | – | 175 |
|
|
2018
Q1 | $3.05M | Sell |
178,402
-1,025,784
| -85% | -$17.5M | 0.05% | 153 |
|
|
2017
Q4 | $22.8M | Buy |
1,204,186
+250,732
| +26% | +$4.75M | 0.3% | 105 |
|
|
2017
Q3 | $16.8M | Sell |
953,454
-13,825
| -1% | -$243K | 0.21% | 120 |
|
|
2017
Q2 | $32.1M | Buy |
967,279
+41,100
| +4% | +$1.37M | 0.44% | 88 |
|
|
2017
Q1 | $29.8M | Buy |
926,179
+67,302
| +8% | +$2.17M | 0.39% | 93 |
|
|
2016
Q4 | $31.1M | Sell |
858,877
-1,804,754
| -68% | -$65.4M | 0.42% | 86 |
|
|
2016
Q3 | $123M | Buy |
2,663,631
+985,790
| +59% | +$45.4M | 1.78% | 7 |
|
|
2016
Q2 | $84.3M | Sell |
1,677,841
-283,367
| -14% | -$14.2M | 1.45% | 19 |
|
|
2016
Q1 | $105M | Buy |
1,961,208
+581,065
| +42% | +$31.1M | 1.64% | 14 |
|
|
2015
Q4 | $90.6M | Sell |
1,380,143
-1,028,683
| -43% | -$67.5M | 1.4% | 17 |
|
|
2015
Q3 | $136M | Sell |
2,408,826
-575,780
| -19% | -$32.5M | 2.09% | 4 |
|
|
2015
Q2 | $171M | Sell |
2,984,606
-684,473
| -19% | -$39.1M | 2.36% | 3 |
|
|
2015
Q1 | $229M | Sell |
3,669,079
-342,108
| -9% | -$21.3M | 2.85% | 1 |
|
|
2014
Q4 | $231M | Sell |
4,011,187
-686,930
| -15% | -$39.5M | 2.77% | 1 |
|
|
2014
Q3 | $249M | Sell |
4,698,117
-387,600
| -8% | -$20.5M | 2.73% | 2 |
|
|
2014
Q2 | $267M | Sell |
5,085,717
-1,208,938
| -19% | -$63.4M | 2.68% | 4 |
|
|
2014
Q1 | $333M | Buy |
6,294,655
+302,295
| +5% | +$16M | 2.91% | 4 |
|
|
2013
Q4 | $240M | Sell |
5,992,360
-140,553
| -2% | -$5.63M | 2.1% | 18 |
|
|
2013
Q3 | $232M | Sell |
6,132,913
-645,626
| -10% | -$24.4M | 2.2% | 17 |
|
|
2013
Q2 | $266M | Buy |
+6,778,539
| New | +$266M | 2.31% | 17 |
|